Rituximab as first-line treatment of patients with follicular lymphoma (FL) and a low-burden tumor: Clinical and molecular evaluation.

被引：0
|
作者：
Solal-Celigny, P
Salles, G
Brousse, N
Eftekhari, P
Soubeyran, P
Lacotte, L
Deconinck, E
Haioun, C
Foussard, C
Sebban, C
Stamatoulas, A
Milpied, N
Boue, F
Taillan, B
Lederlin, P
Najman, A
Mathieu-Boue, A
Benzohra, A
Colombat, P
机构：
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2802
引用
收藏
页码：631A / 631A
页数：1
相关论文
共 50 条
  • [41] Rituximab Maintenance Therapy After First-Line induction Chemoimmunotherapy for Follicular Lymphoma
    Hilal, Talal
    Leis, Jose F.
    Reeder, Craig B.
    JAMA ONCOLOGY, 2018, 4 (06) : 859 - 860
  • [42] The societal impact of obinutuzumab in the first-line treatment of patients with follicular lymphoma in Germany
    Hofmann, Sarah
    Himmler, Sebastian
    Ostwald, Dennis
    Duenzinger, Ulrich
    Launonen, Aino
    Thuresson, Per-Olof
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (14) : 1017 - 1026
  • [43] High Risk of Transformation and Secondary Malignancies in Follicular Lymphoma Patients Treated With First-line Bendamustine Rituximab and Rituximab Maintenance
    Rangel-Patino, Juan
    Kridel, Robert
    Kuruvilla, John
    Prica, Anca
    Kukreti, Vishal
    Bhella, Sita
    Delabie, Jan
    Vijenthira, Abi
    Crump, Michael
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S503 - S503
  • [44] Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study (vol 41, pg 3523, 2023)
    Cartron
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (25) : 4187 - 4187
  • [45] Rituximab for the first-line treatment of stage III/IV follicular non-Hodgkin's lymphoma
    Dundar, Y.
    Bagust, A.
    Hounsome, J.
    McLeod, C.
    Boland, A.
    Davis, H.
    Walley, T.
    Dickson, R.
    HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 23 - 28
  • [46] The association of rituximab with CHOP in first-line treatment brings a significant benefit in the advanced stages of follicular lymphoma
    Choquet, Sylvain
    HEMATOLOGIE, 2006, 12 (01): : 13 - 14
  • [47] First-line treatment of follicular lymphoma (FL) with golcadamide, rituximab plus /- nivolumab: An umbrella randomised phase 2 investigator-led study.
    Chong, Geoffrey
    Palmer, Jodie
    Barraclough, Allison
    Churilov, Leonid
    Keane, Colm
    Lee, Sze Ting
    Lee, Denise
    Ratnasingam, Sumita
    Smith, Charmaine
    Hawkes, Eliza Anne
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [48] Patterns and Outcomes Of First-Line Management Strategies In Older Adults With Low-Grade Follicular Lymphoma (FL)
    Rai, Ashish
    Nastoupil, Loretta J.
    Lipscomb, Joseph
    Ward, Kevin
    Howard, David H.
    Flowers, Christopher R.
    BLOOD, 2013, 122 (21)
  • [49] Early stage follicular lymphoma: what is the clinical impact of the first-line treatment strategy?
    Anne-Sophie AS Michallet
    Laure L Lebras
    Deborah D Bauwens
    Fadhela F Bouafia-Sauvy
    Françoise F Berger
    Christelle C Tychyj-Pinel
    Anne A D’Hombres
    Gilles G Salles
    Bertrand B Coiffier
    Journal of Hematology & Oncology, 6
  • [50] Early stage follicular lymphoma: what is the clinical impact of the first-line treatment strategy?
    Michallet, Anne-Sophie A. S.
    Lebras, Laure L.
    Bauwens, Deborah D.
    Bouafia-Sauvy, Fadhela F.
    Berger, Francoise F.
    Tychyj-Pinel, Christelle C.
    D'Hombres, Anne A.
    Salles, Gilles G.
    Coiffier, Bertrand B.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
12345